» Articles » PMID: 30247717

Pancreatic β-cell TRNA Hypomethylation and Fragmentation Link TRMT10A Deficiency with Diabetes

Abstract

Transfer RNAs (tRNAs) are non-coding RNA molecules essential for protein synthesis. Post-transcriptionally they are heavily modified to improve their function, folding and stability. Intronic polymorphisms in CDKAL1, a tRNA methylthiotransferase, are associated with increased type 2 diabetes risk. Loss-of-function mutations in TRMT10A, a tRNA methyltransferase, are a monogenic cause of early onset diabetes and microcephaly. Here we confirm the role of TRMT10A as a guanosine 9 tRNA methyltransferase, and identify tRNAGln and tRNAiMeth as two of its targets. Using RNA interference and induced pluripotent stem cell-derived pancreatic β-like cells from healthy controls and TRMT10A-deficient patients we demonstrate that TRMT10A deficiency induces oxidative stress and triggers the intrinsic pathway of apoptosis in β-cells. We show that tRNA guanosine 9 hypomethylation leads to tRNAGln fragmentation and that 5'-tRNAGln fragments mediate TRMT10A deficiency-induced β-cell death. This study unmasks tRNA hypomethylation and fragmentation as a hitherto unknown mechanism of pancreatic β-cell demise relevant to monogenic and polygenic forms of diabetes.

Citing Articles

The functions and modifications of tRNA-derived small RNAs in cancer biology.

Saad A, Zhang K, Deng Q, Zhou J, Ge L, Wang H Cancer Metastasis Rev. 2025; 44(1):38.

PMID: 40072687 DOI: 10.1007/s10555-025-10254-6.


The role of tRNA-Derived small RNAs (tsRNAs) in pancreatic cancer and acute pancreatitis.

Pan Y, Ying X, Zhang X, Jiang H, Yan J, Duan S Noncoding RNA Res. 2025; 11:200-208.

PMID: 39896345 PMC: 11786804. DOI: 10.1016/j.ncrna.2024.12.011.


tRNA-derived small RNAs: their role in the mechanisms, biomarkers, and therapeutic strategies of colorectal cancer.

Zhang B, Pan Y, Li Z, Hu K J Transl Med. 2025; 23(1):51.

PMID: 39806419 PMC: 11727791. DOI: 10.1186/s12967-025-06109-x.


Screening of obstructive sleep apnea and diabetes mellitus -related biomarkers based on integrated bioinformatics analysis and machine learning.

Yang J, Han Y, Diao X, Yuan B, Gu J Sleep Breath. 2025; 29(1):74.

PMID: 39804507 PMC: 11729194. DOI: 10.1007/s11325-024-03240-9.


The N6-methyladenosine RNA epigenetic modification modulates the amplification of coxsackievirus B1 in human pancreatic beta cells.

Bonfim M, Aitchedji C, Van Goethem F, Sauvage L, Poinsot T, Calonne E Front Microbiol. 2025; 15:1501061.

PMID: 39744389 PMC: 11688287. DOI: 10.3389/fmicb.2024.1501061.


References
1.
Kadaba S, Krueger A, Trice T, Krecic A, Hinnebusch A, Anderson J . Nuclear surveillance and degradation of hypomodified initiator tRNAMet in S. cerevisiae. Genes Dev. 2004; 18(11):1227-40. PMC: 420349. DOI: 10.1101/gad.1183804. View

2.
Saxena R, Voight B, Lyssenko V, Burtt N, de Bakker P, Chen H . Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316(5829):1331-6. DOI: 10.1126/science.1142358. View

3.
Xie P, Wei F, Hirata S, Kaitsuka T, Suzuki T, Suzuki T . Quantitative PCR measurement of tRNA 2-methylthio modification for assessing type 2 diabetes risk. Clin Chem. 2013; 59(11):1604-12. DOI: 10.1373/clinchem.2013.210401. View

4.
Gustavsson M, Ronne H . Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast. RNA. 2008; 14(4):666-74. PMC: 2271368. DOI: 10.1261/rna.966208. View

5.
Grosjean H, de Crecy-Lagard V, Marck C . Deciphering synonymous codons in the three domains of life: co-evolution with specific tRNA modification enzymes. FEBS Lett. 2009; 584(2):252-64. DOI: 10.1016/j.febslet.2009.11.052. View